Skip to main content

and
  1. Article

    Open Access

    Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry

    The use of peripheral blood (PB) or bone marrow (BM) stem cells graft in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide (PTCy) for graft-versus-host disease (GVHD)...

    Claire Lacan, Jérôme Lambert, Edouard Forcade in Journal of Hematology & Oncology (2024)

  2. No Access

    Article

    Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002

    Gabrielle Meyers, Mehdi Hamadani, Michael Martens, Haris Ali in Bone Marrow Transplantation (2023)

  3. No Access

    Article

    Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC

    We report the results from a multicentre retrospective study of 220 adult patients who underwent allogeneic hematopoietic stem cell transplantation (alloHSCT) for therapy-related acute myeloid leukaemia (t-AML...

    Gaëlle Rey, Elisabeth Daguenet, Paul Bonjean in Bone Marrow Transplantation (2023)

  4. Article

    Open Access

    Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS

    Allogeneic hematopoietic stem cell transplantation remains the best curative option for higher-risk myelodysplastic syndrome. The presence of monosomal karyotype and/or complex karyotype abnormalities predicts...

    Claire Michel, Marie Robin, Stephane Morisset, Didier Blaise in Bone Marrow Transplantation (2023)

  5. No Access

    Article

    Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC

    Relapsed B-cell acute lymphoblastic leukemia (B-ALL) after allogeneic stem cell transplantation (allo-HCT) still represents a major concern with poor outcomes. The aim of this study is to compare the efficacy ...

    Paul Chauvet, Annalisa Paviglianiti, Myriam Labopin in Bone Marrow Transplantation (2023)

  6. Article

    Open Access

    Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC

    Since the emergence of the Omicron variant of SARS-CoV-2, though considered less virulent, hospitalization and death rates among immunocompromised patients remain high, especially for poor responders to vaccin...

    Ludovic Jondreville, Maud D’Aveni in Journal of Hematology & Oncology (2022)

  7. No Access

    Article

    Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life—experience of the French Network

    We analysed the therapeutic outcomes of all consecutive patients with primary central nervous system lymphoma (PCNSL) registered in the prospective French database for PCNSL and treated with intensive chemothe...

    Laurence Schenone, Caroline Houillier, Marie Laure Tanguy in Bone Marrow Transplantation (2022)

  8. Article

    Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groups

    This multicenter prospective phase 2 trial analyzed disease-free survival (DFS) in myelofibrosis patients receiving ruxolitinib for 6 months before transplantation. Seventy-six patients were recruited. Age-adj...

    Marie Robin, Raphael Porcher, Corentin Orvain in Bone Marrow Transplantation (2021)

  9. No Access

    Article

    Performance evaluation of a new mobile air-treatment technology at-rest and under normal work conditions in a conventional hematology room

    Invasive fungal infections incidence in patients with hematological malignancies is increasing. Air treatment remains an essential preventive measure. Guidelines state that high-risk patients should be housed ...

    Anne Pouvaret, Emmanuelle Tavernier, Jérôme Cornillon in Health and Technology (2020)

  10. No Access

    Article

    Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

    Several approaches have been developed to overcome historical barriers associated with poor outcomes in the setting of HLA-haploidentical allogeneic transplantation (HaploSCT). Here, we examine the outcome of ...

    Amandine Fayard, Elisabeth Daguenet, Didier Blaise in Bone Marrow Transplantation (2019)

  11. No Access

    Article

    BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

    High-dose chemotherapy before autologous transplantation is a therapeutic option as consolidation in primary or relapsed lymphoma. Even if BEAM conditioning is generally used, alternative conditioning regimens...

    Jérôme Cornillon, Elisabeth Daguenet, Jacques-Olivier Bay in Annals of Hematology (2019)

  12. Article

    Cytotect®CP as salvage therapy in patients with CMV infection following allogeneic hematopoietic cell transplantation: a multicenter retrospective study

    Cytomegalovirus is one of the main contributing factors to high mortality rates in patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT). The main factors of treatment failure are both d...

    Tamim Alsuliman, Caroline Kitel, Rémy Dulery in Bone Marrow Transplantation (2018)

  13. Article

    Open Access

    Fulminant hepatitis due to very severe sinusoidal obstruction syndrome (SOS/VOD) after autologous peripheral stem cell transplantation: a case report

    Hepatic veno-occlusive disease, also called sinusoidal obstruction syndrome (SOS/VOD), is a potentially fatal complication of allogeneic or autologous hematopoietic stem cell transplantation. A plethora of tra...

    Emmanuelle Tavernier, Emilie Chalayer, Jérôme Cornillon in BMC Research Notes (2018)

  14. No Access

    Article

    Extending autologous transplantation as first line therapy in multiple myeloma patients with severe renal impairment: a retrospective study by the SFGM-TC

    Renal impairment is a common complication of multiple myeloma (MM), accounting for 20–30% of MM patients at diagnosis and 40–50% of patients during the course of their disease. This feature is associated with ...

    Karine Augeul-Meunier, Marie-Lorraine Chretien in Bone Marrow Transplantation (2018)

  15. Article

    Open Access

    Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation

    Allogeneic hematopoietic stem cell transplantation is mainly indicated in bone marrow dysfunction related to blood diseases, but also in some rare diseases (adrenoleucodystrophy, mitochondrial neurogastrointes...

    Marie-Christine Vantyghem, Jérôme Cornillon in Orphanet Journal of Rare Diseases (2014)

  16. No Access

    Article

    HSP90 inhibition results in apoptosis of Philadelphia acute lymphoblastic leukaemia cells: an attractive prospect of new targeted agents

    HSP90 targeting is a promising therapeutic approach in cancer. 17-AAG is an HSP90 inhibitor with completed Phase I trials in patients with advanced cancer and recently published Phase II trials. The aim of thi...

    Emmanuelle Tavernier in Journal of Cancer Research and Clinical On… (2012)

  17. No Access

    Article

    Significance of heat-shock protein (HSP) 90 expression in acute myeloid leukemia cells

    The 90-kDa heat shock protein (HSP90) is implicated in the conformational maturation and stabilization of a variety of client proteins with receptor and signal transduction functions. The objective of this stu...

    Pascale Flandrin, Denis Guyotat, Amélie Duval in Cell Stress and Chaperones (2008)

  18. No Access

    Article

    Correlation between 99mTc-(V)-DMSA uptake and constitutive level of phosphorylated focal adhesion kinase in an in vitro model of cancer cell lines

    Although a number of prognostic indicators have been developed, it is still difficult to predict the biological behaviour of all cancer types. 99mTc-(V)-DMSA (V DMSA) uptake and focal adhesion kinase (FAK) expres...

    Delphine Denoyer, Nathalie Perek in European Journal of Nuclear Medicine and M… (2005)